A clinical case of inflammatory cardiomyopathy due to experienced subacute viral myocarditis associated with the new coronavirus infection COVID-19 of occupational genesis

DOI: https://doi.org/10.29296/25877305-2022-01-06
Issue: 
1
Year: 
2022

Professor S. Babanov(1), MD; Associate Professor T. Azovskaya(1), Candidate of Medical
Sciences; Associate Professor N. Vakurova(1), Candidate of Medical Sciences; Associate Professor N.
Lavrentyeva(1), Candidate of Medical Sciences; R. Baraeva(2), Candidate of Medical Sciences; Associate
Professor A. Ryabov(1), Candidate of Medical Sciences; A. Agarkova(1); N. Ostryakova(1) (1)Samara State
Medical University, Ministry of Health of Russia (2)Samara Primary Healthcare Unit Five, Kirovsky District

Health care workers are increased risk group of SARS-CoV-2 infection when providing medical care. The novel coronavirus infection (NCI) in healthcare workers can be considered an occupational disease if the infection occurs when they fulfil their professional duties. Damage to the cardiovascular system is one of the most important complications of NCI. The paper describes a clinical case of a serious NCI complication that develops in the presence of chronic autoimmune disease - severe myocarditis with pulmonary embolism, which leads to inflammatory cardiomyopathy with congestive heart failure in a healthcare worker. The paper presents the principles and results of a medical examination made to establish a causal relationship between the disease and professional activities.
Keywords: 
infectious diseases
novel coronavirus infection (COVID-19)
inflammatory cardiomyopathy
occupational diseases
healthcare workers

References: 
  1. Buhtijarov I.V. Sovremennoe sostojanie i osnovnye napravlenija sohranenija i ukreplenija zdorov'ja rabotajuschego naselenija Rossii. Meditsina truda i promyshlennaja ekologija. 2019; 59 (9): 527–32 [Bukhtiyarov I.V. Current state and main directions of preservation and strengthening of health of the working population of Russia. Russian Journal of Occupational Health and Industrial Ecology. 2019; 9: 527–32 (in Russ.)]. DOI: 10.31089/1026-9428-2019-59-9-527-532
  2. Babanov S.A. Voprosy ekspertizy i dopolnitel'nyh strahovyh garantij otdel'nym kategorijam meditsinskih rabotnikov pri infitsirovanii novoj koronavirusnoj infektsiej COVID-19. Terapevt. 2020; 10: 16–27 [Babanov S.A. Issues of expert examination and additional insurance guarantees for certain categories of medical workers in case of infecting with the novel coronavirus infection COVID-19. Terapevt. 2020; 10: 16–27 (in Russ.)]. DOI: 10.33920/MED-12-2010-02
  3. Garipova R.V., Strizhakov L.A., Babanov S.A. Novaja koronavirusnaja infektsija kak professional'noe zabolevanie: slozhnye ekspertnye sluchai. Mat-ly 16 Vseross. Kongr. «Professija i zdorov'e». Vladivostok, 2021 [Garipova R.V., Strizhakov L.A., Babanov S.A. Novaya koronavirusnaya infektsiya kak professional’noe zabolevanie: slozhnye ekspertnye sluchai. Mat-ly 16 Vseross. Kongr. «Professiya i zdorov’e». Vladivostok, 2021 (in Russ.)].
  4. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210 [Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.)]. DOI: 10.33029/0206-4952-2021-42-3-198-210
  5. Kosarev V.V., Babanov S.A. Professional'nye zabolevanija meditsinskih rabotnikov. Samara: OOO «Ofort», 2014; 201 s. [Kosarev V.V., Babanov S.A. Professional’nye zabolevaniya meditsinskikh rabotnikov. Samara: OOO «Ofort», 2014; 201 s. (in Russ.)]
  6. Kudlaj D.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika COVID-19. Sposoby i problemy obnaruzhenija virusa SARS-COV-2 v uslovijah pandemii. Vrach. 2020; 31 (8): 5–10 [Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.)]. DOI: 10.29296/25877305-2020-08-01
  7. Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19)». Versija 13 (134.102021) [Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19)». Versiya 13 (134.102021) (in Russ.)].
  8. Gipertroficheskaja kardiomiopatija. Klinicheskie rekomendatsii. M.: Rossijskoe kardiologicheskoe obschestvo, 2020; 151 s. [Gipertroficheskaya kardiomiopatiya. Klinicheskie rekomendatsii. M.: Rossiiskoe kardiologicheskoe obshchestvo, 2020; 151 s. (in Russ.)].
  9. Kardiologija. Natsional'noe rukovodstvo: kratkoe izdanie. Pod red. Ju.N. Belenkova, R.G. Oganova. M.: GEOTAR-Media, 2012; 848 s. [Kardiologiya. Natsional’noe rukovodstvo: kratkoe izdanie. Pod red. Yu.N. Belenkova, R.G. Oganova. M.: GEOTAR-Media, 2012; 848 s. (in Russ.)].
  10. Miokardity. Klinicheskie rekomendatsii Minzdrava Rossii, 2020 [Miokardity. Klinicheskie rekomendatsii Minzdrava Rossii, 2020 (in Russ.)].
  11. Novaja koronavirusnaja infektsija COVID-19: professional'nye aspekty sohranenija zdorov'ja i bezopasnosti meditsinskih rabotnikov: metodicheskie rekomendatsii. Pod red. I.V. Buhtijarova, Ju.Ju. Gorbljanskogo. M.: AMT, FGBNU «NII MT», 2021; 132 c. [Novaya koronavirusnaya infektsiya COVID-19: professional’nye aspekty sokhraneniya zdorov’ya i bezopasnosti meditsinskikh rabotnikov: metodicheskie rekomendatsii. Pod red. I.V. Bukhtiyarova, Yu.Yu. Gorblyanskogo. M.: AMT, FGBNU «NII MT», 2021; 132 s. (in Russ.)].
  12. Shljahto E.V. Kardiologija. Natsional'noe rukovodstvo. M.: GEOTAR-Media, 2018 [Shlyakhto E.V. Kardiologiya. Natsional’noe rukovodstvo. M.: GEOTAR-Media, 2018 (in Russ.)].
  13. Burdorf A., Porru F., Rugulies R. The COVID-19 (Coronavirus) pandemic: Consequences for occupational health. Scand J Work Environ Health. 2020; 46 (3): 229–30. DOI: 10.5271/sjweh.3893.
  14. Malkova A., Kudlay D., Kudryavtsev I. et al. Immunogenetic Predictors of Severe COVID-19. Vaccines. 2021; 9: 211. DOI: 10.3390/vaccines9030211
  15. Maron B.J. et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113 (14): 1807–16. DOI: 10.1161/CIRCULATIONAHA.106.174287
  16. Yancy C.W. et al. ACCF/AHA Guideline for the Managegment of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62 (16): e147–239. DOI: 10.1016/j.jacc.2013.05.019